Canadian government officials are being urged to allow First Nations peoples the ability to regulate their own cannabis production and sales.
Canadian Senate Committee on Indigenous Peoples is calling for their government to grant First Nations peoples the opportunity to regulate their own cannabis production, as well as sales (1). The committee published a report (2) mentioning how First Nations people have not been provided the same economic circumstances created from the legalization of cannabis. This chamber also has witnessed that previous complaints made by First Nations before cannabis’s legalization, have not been answered. One example listed was that exclusive power would be given to the federal government allowing them to regulate matters related to First Nations and their reserve lands.
When the Cannabis Act was being discussed in 2018 (1), representatives of First Nations challenged how giving them jurisdiction over the distribution, sale, and regulation of cannabis was “an essential element of their inherent right to self-government and would ensure their full participation in the economic opportunities that legalization was to provide,” (1). By disregarding this topic, First Nations feel they have been excluded from the cannabis market and are asking for the Minister of Health to draw up new legislation to rectify the Cannabis Act.
Reported to MJ Biz Daily, a spokesperson for Health Canada, stated that they encourage the growth of an inclusive and diverse cannabis industry. “As part of this commitment, the department has taken targeted actions to assist interested Indigenous communities with their participation in the cannabis industry, including the establishment of an Indigenous Navigator Service,” the Health Canada spokesperson commented (1).
The Senate Committee on Indigenous Peoples also is working to increase funding for policing and enforcement of First Nations cannabis laws, as well as, more funding and training targeting First Nations police services.
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.